Octapharma clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
- Notable: Panzyga in Primary Infection Prophylaxis · Chronic Lymphocytic Leukemia ("PRO-SID" Study) Results posted: Nov 2, 2026
- Minor: Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections Trial sites expanded: 17 → 25 locations
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 3 | 6 | |
| Phase 4 | 2 |
Not charted: 3 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Hemophilia (3)
Get alerts when Octapharma's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.